Skip to main content

Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation

Newswire.ca - Tue Jul 22, 2025

House Appropriations Committee Champions Greater Nutritional Choice and Market Access for U.S. Families

FDA Directed to Streamline Approval Pathways for Plant-Based Infant Formulas, Positioning Else Nutrition to Capitalize on Legislative Momentum and Rising Consumer Demand

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).